StockMarketWire.com - Biotherapeutics company PureTech Health said founded entity and oncology company Vor Biopharma had appointed Matthew R Patterson to its board.

Patterson was co-founder of Audentes Therapeutics and was its chief executive for eight years until its acquisition by Astellas Pharma in 2020.


At 1:23pm: [LON:PRTC] Puretech Health PLC share price was -8.5p at 241.5p



Story provided by StockMarketWire.com